Deltec Asset Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Deltec Asset Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-72,290	Closed	-$4.47M	–	246
2022 Q3	$4.47M	Sell	72,290 -14,280	-16%	-$998K	1.1%	19
2022 Q2	$6.91M	Buy	86,570 +39,100	+82%	+$3.7M	1.62%	15
2022 Q1	$4.99M	Sell	47,470 -18,840	-28%	-$1.84M	0.85%	30
2021 Q4	$7.15M	Sell	66,310 -440	-0.7%	-$48K	1.16%	25
2021 Q3	$7.31M	Sell	66,750 -77,850	-54%	-$8.08M	1.1%	22
2021 Q2	$13.5M	Hold	144,600	–	–	1.86%	11
2021 Q1	$13.3M	Sell	144,600 -3,000	-2%	-$253K	1.98%	11
2020 Q4	$10.8M	Buy	147,600 +50,100	+51%	+$3.72M	1.65%	12
2020 Q3	$7.57M	Buy	+97,500	New	+$6.71M	1.35%	17
2018 Q3	–	Sell	-21,400	Closed	-$354K	–	193
2018 Q2	$354K	Sell	21,400 -300	-1%	-$4.58K	0.07%	142
2018 Q1	$308K	Sell	21,700 -12,000	-36%	-$177K	0.06%	154
2017 Q4	$492K	Sell	33,700 -100,000	-75%	-$1.4M	0.1%	123
2017 Q3	$1.7M	Sell	133,700 -109,000	-45%	-$1.39M	0.34%	72
2017 Q2	$2.88M	Buy	242,700 +46,922	+24%	+$584K	0.59%	64
2017 Q1	$2.89M	Buy	195,778 +50,078	+34%	+$811K	0.59%	63
2016 Q4	$2.36M	Sell	145,700 -46,150	-24%	-$837K	0.55%	59
2016 Q3	$3.48M	Buy	191,850 +27,450	+17%	+$536K	0.79%	43
2016 Q2	$2.71M	Hold	164,400	–	–	0.68%	44
2016 Q1	$2.72M	Buy	164,400 +154,400	+1,544%	+$2.7M	0.68%	43
2015 Q4	$217K	Hold	10,000	–	–	0.06%	130
2015 Q3	$198K	Buy	+10,000	New	+$316K	0.05%	156

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

HBK Investments Dallas, Texas $10.3B AUM 67.69% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Deltec Asset Management's HZNP Position: Q4 2022 in Review

Deltec Asset Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2022, closing a stake of 72,290 shares — an estimated $4.47M sold.

Deltec Asset Management first reported a position in HZNP in Q3 2015 and held it in 21 quarters. The position peaked at $13.5M in Q2 2021. 613 funds tracked by Wall St. Rank hold HZNP as of Q4 2022.

Deltec Asset Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2022 after selling out during the quarter.
Deltec Asset Management sold 72,290 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2022, an estimated $4.47M.
Deltec Asset Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2015 and held it in 21 quarters.
Deltec Asset Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $13.5M in Q2 2021.
613 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2022.

Based on Deltec Asset Management's 13F filing for Q4 2022, filed 25 Jan 2023.